Last Price
0.024
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Overview
Market Cap
0
Shares Outstanding
0
Avg Volume
0
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.00
PE Ratio
0.00
EPS
0.00
Earnings Announcement
Previous Close
0.00
Open
0.00
Day's Range
0.0 - 0.0
Year Range
0.0 - 0.0
Trading Volume
0
Price Change Highlight
1 Day Change
5 Day Change
1 Month Change
3 Month Change
6 Month Change
Ytd Change
1 Year Change
3 Year Change
5 Year Change
10 Year Change
Max Change
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Description:
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
![[New IPO] Icents Group Holdings Berhad, a specialised construction company focused on cleanroom EPCC services for industries, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1192/Thumbnail__(9).png)
![[New IPO] A1 A.K. Koh Group Berhad, a well-established brand owner in the processed F&B industry, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1186/Thumbnail__(8).png)
![[New IPO] PMCK Berhad, a healthcare services provider, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1180/Thumbnail__(7).png)
Apps
Top Articles
Daily Stocks
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
